news updates

Pharmeasy IPO


Founded in 2015

Founders – Dharmil Sheth and Dhaval Shah Pharm


Chief Executive Officer  –  Dharmil Sheth

Chief Technology Officer – Bhaskar Raju

PharmEasy is basically Pharmacy made Easy and is the largest pharmacy aggregator in India.

Pharmeasy reach

Pharm Easy delivers orders ( medicines and healthcare products) in more than 1,000 cities and towns covering 22,000+ pin codes. It includes Mumbai, Kolkata, Delhi, Bengaluru, Ahmedabad, Hyderabad, and Chennai.

How they work?

  • API Holdings — the parent company of PharmEasy  has appointed five independent directors to its board. Pharm Easy  India’s biggest online pharmacy is likely to file its IPO papers by October for a listing later in the fiscal year.
  • In less than four months, its valuation jump threefold
  •   April 2021, Pharm Easy raised about $350 million from Prosus Ventures (formerly Naspers) and TPG Growth at a valuation of $1.5 billion, becoming the first Indian e-pharmacy unicorn.
  •   May 2021, Pharm Easy completed the acquisition of smaller rival Medlife to become India’s largest online pharmacy and healthcare aggregator.
  •   June2021, API Holdings bought a controlling stake in Thyrocare Technologies for ₹4,546 crore.
  •  September 2021, Aknamed is into providing supply chain solutions for hospital chains and mid-sized hospitals. PharmEasy is acquiring three-year-old Aknamed for upto $200 million.
  • As of  now, PharmEasy owns 67%  stake in the company followed by Lightstone 31% and other stakeholders hold another 1.4%.
  • As per the filings, PharmEasy has bought out the stake of five promoters of Aknamed — Saurabh Pandey, Mahadevan Narayanamoni, Mayank Kapoor, Shaunak Joshi and Varun Vohra — who collectively controlled a 50.67%.
  • Pharm Easy hired Morgan Stanley and Kotak Mahindra Capital as advisers for its IPO.


  • Sole purpose is to make affordable healthcare accessible to all in 2015.
  • To help patients connect with local pharmacy stores .
  • To assist diagnostic centres in order to fulfil their extensive medical needs.
  • Make sure that everyone should have access to good health.


Aarin Capital, Astarc Ventures, B Capital Group, Bessemer Venture Partners, Caisse de Dépôt et Placement du Québec, Eight Roads Ventures India, F-Prime Capital Partners, Fundamentum, InnoVen Capital, JM Financial, KB Financial Group, LGT group, Manipal Group, Orios Venture Partners, Prosus Ventures, Temasek Holdings, Think Investments, TPG Growth, Trifecta Capital Advisors


  • Important players in the domestic retail pharmacy segment both online and offline:
  • Chennai-based Netmeds was acquired by Reliance Industries (Vitalic Health Pvt. Ltd) for ₹620 crore in August, 2020.
  • Tata Sons Private Limited, acquired a majority stake in digital health company 1MG Technologies Private Ltd. (“1MG”) in June, 2021.
  • Amazon pharmacy  (launched by Amazon last year in Bengaluru).
  • Apollo Pharmacy.

Ø  Others include Warburg Pincus and PremjiInvest-Backed Medplus


According to the data from the Department of Industrial Policy and Promotion, the Indian retail pharmacy segment is estimated to be worth $18 billion and is expected to touch $50 billion by 2025.

The E-pharma space is estimated to grow at an annual average growth rate of 18.1% to reach $18.1 billion by 2023.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button